Posted on

Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.

Cellution Biologics acquires SimpliDerm®, expanding its human tissue portfolio and entering the U.S. reconstructive surgery market.

Go to Source

By sf-admin